OakChart

IRIDEX Corp

IRIXHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 12:09 PM ET

0.6501-0.0501 (-7.16%)
2026-11-11 18:15 CET
Market cap
12.30 USD m
Revenue, TTM
51.57 USD m
Net income, TTM
-3.55 USD m
Free cash flow, TTM
-2.00 USD m
EPS diluted, TTM
-0.21
P/E
-
Compare

Price

IRIX against its 20, 50 and 200-day averages
2050200earnings
0.600.801.001.209.9M19.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26IRIXclose 0.6520-day 0.7350-day 0.71200-day 1.010.6552w low

60.6% under the 52-week high of 1.65 on 22 Jan 2026. 52-week low 0.61 on 16 Sep 2026. Last 15 sessions, 21.0% high to low

Profile

IRIX
52-week range, 4% of the way up
0.611.65

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Employees93
IPOFeb 16, 1996
Beta0.63
ATR, 14d0.06
Rel volume0.13
Short float0.37%
Insider own38.84%
Inst own17.19%

Snapshot

6 groups

Valuation

Index-
Market Cap11.42M
Enterprise Value16.75M
Income-3.55M
Sales51.57M
Book/sh-0.14
Cash/sh0.27
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees93
IPOFeb 16, 1996

Ratios

P/E-
Forward P/E-
PEG-
P/S0.22
P/B-
P/C2.44
P/FCF-
EV/EBITDA-
EV/Sales0.32
Quick Ratio1.08
Current Ratio1.82
Debt/Eq1.10
LT Debt/Eq1.06
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.21
EPS next Y0.00
EPS next Q-0.04
EPS this Y53.85%
EPS next Y100.00%
EPS next 5Y-
EPS past 3/5Y17.90% 10.54%
Sales past 3/5Y-2.58% 7.70%
EPS Y/Y TTM36.91%
Sales Y/Y TTM3.68%
EPS Q/Q-22.80%
Sales Q/Q-7.41%
EarningsNov 17 AMC
EPS/Sales Surpr.-600.00% -7.51%

Ownership

Insider Own38.84%
Insider Trans21.87%
Inst Own17.19%
Inst Trans-0.92%
ROA-12.06%
ROE-73.15%
ROIC-47.22%
Gross Margin35.31%
Oper. Margin-5.39%
Profit Margin-6.88%
SMA20-11.20%
SMA50-8.77%
SMA200-35.47%
Trades-

Technical

Shs Outstand17.45M
Shs Float10.74M
Short Float0.37%
Short Ratio0.10
Short Interest0.04M
52W High1.65 -60.55%
52W Low0.61 7.10%
Volatility7.53% 8.00%
ATR (14)0.06
RSI (14)38.34
Beta0.63
Rel Volume0.13
Avg Volume385.37K
Volume23,106

Performance

Perf Week-9.09%
Perf Month-23.36%
Perf Quarter-21.11%
Perf Half Y-36.88%
Perf YTD-42.97%
Perf Year-45.37%
Perf 3Y-68.75%
Perf 5Y-92.78%
Perf 10Y-95.97%
Recom1.00
Target Price2.75
Prev Close0.70
Price0.65
Change %-7.16%

Analyst ratings

latest 4 of 4
DateActionAnalystRating changeTargetImplied
Nov 03, 2017ResumedRROTH CapitalBuy
Dec 21, 2016InitiatedRROTH CapitalBuy
Jan 26, 2016InitiatedSSingular ResearchBuy$11.50+1,669.0%
Jan 03, 2007InitiatedFFirst AlbanyBuy$15.50+2,284.2%

Peers

Mkt cap
TickerCompanyMkt cap
LNSRLENSAR Inc54.80M
GKOSGlaukos Corp14.49B
SGHTSight Sciences Inc599.14M
RXSTRxSight Inc205.24M
SRTSSensus Healthcare Inc55.47M
ALCAlcon Inc34.48B
APYXApyx Medical Corp123.42M
BLCOBausch + Lomb Corp7.58B
STAAStaar Surgical Co1.28B
HROWHarrow Inc1.08B

Insider trading

latest 14 of 70
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Lin Shih-Yao David10% OwnerFeb 05 '26Buy1.4540,53558,7551,098,858Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerJan 27 '26Buy1.4833,01349,0141,034,312Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerJan 23 '26Buy1.4830,00044,3941,001,299Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerMar 17 '26Buy1.3122,80529,8721,157,363Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerFeb 04 '26Buy1.4119,32427,2471,058,323Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerJan 08 '26Buy1.2020,00024,000971,299Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerMar 23 '26Buy1.3317,52623,3101,174,889Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerFeb 11 '26Buy1.4315,70322,4551,114,690Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerFeb 23 '26Buy1.4114,94321,0701,129,733Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerDec 12 '25Buy0.9720,00019,400905,648Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerDec 09 '25Buy0.9420,00018,800866,756Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerDec 10 '25Buy0.9418,89217,664885,648Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerDec 19 '25Buy0.9714,20213,776938,929Oct 07 06:10 AM
Lin Shih-Yao David10% OwnerDec 15 '25Buy0.9411,40410,720917,052Oct 07 06:10 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 204
  • Iridex Must Prove Its Back-Half Rebound Is Real As Retina Weakness Tests Guidance (Earnings Whispers) -7.16%
  • Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026 (GlobeNewswire)
  • Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse Technology for Early to Advanced Glaucoma (GlobeNewswire)
  • Iridex Completes Relocation of Manufacturing Facility to San Jose, California (GlobeNewswire) +7.28%
  • IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 Surges 35% as Company Achieves ... (GuruFocus.com) -15.83%
  • Loading…
  • Iridex: Q2 Earnings Snapshot (Associated Press) +5.69%
  • Iridex Reports Second Quarter 2026 Financial Results (GlobeNewswire)
  • Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 (GlobeNewswire)
  • Iridex Adds EndoProbe Handpieces to EyeProGPO Product Offering (GlobeNewswire)
  • Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference (GlobeNewswire)
  • IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
  • Iridex: Q1 Earnings Snapshot (Associated Press)
  • Iridex Reports First Quarter 2026 Financial Results (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-17--0.040--12.651
2026Q22026-08-18-0.070-0.010-0.07012.5713.591
2026Q12026-05-19-0.030-0.070-0.03011.8011.911
2025Q42026-03-26-0.010-0.020-0.01114.7214.741
2025Q32025-11-11-0.090--0.09312.48--
2025Q22025-08-12-0.060--0.05913.57--
2025Q12025-05-13-0.100--0.10111.90--
2024Q42025-03-27-0.050--0.05012.70--
2024Q32024-11-12-0.120--0.11711.58--
2024Q22024-08-08-0.160-0.120-0.16512.6312.801
2024Q12024-05-14-0.210-0.120-0.21311.7612.001
2023Q42024-03-26-0.180-0.050-0.18212.4614.901
2023Q32023-11-14-0.110-0.125-0.10812.8513.482
2023Q22023-08-10-0.170-0.110-0.17312.8614.232
2023Q12023-05-11-0.130-0.120-0.13113.7113.642
2022Q42023-03-09-0.070-0.110-0.07215.2015.162

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-1.110-0.930-1.11041.5941.57
2018FY-1.050-1.085-1.05042.6042.00
2019FY-0.640-0.685-0.64343.4542.57
2020FY-0.460-0.550-0.45736.3536.28
2021FY-0.340-0.295-0.33953.9053.31
2022FY-0.470-0.515-0.47456.9756.95
2023FY-0.590-0.460-0.59351.8754.30
2024FY-0.540--0.54248.67-
2025FY-0.260-0.270-0.26052.6852.69
2026FY--0.120--52.52
2027FY-0.000--55.98
2028FY-0.070--60.01

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-0210012.6512.6512.65
2026Q3S2026-08-1910112.6512.6512.65
2026Q3S2026-08-1810012.9812.9812.98
2026Q3S2026-08-0310012.9812.9812.98
2026Q3S2026-05-2011012.9812.9812.98
2026Q3S2026-03-2710112.7912.7912.79
2026Q3S2026-02-0310013.4213.4213.42
2026Q3E2026-11-02100-0.04-0.04-0.04
2026Q3E2026-08-19101-0.04-0.04-0.04
2026Q3E2026-08-18100-0.02-0.02-0.02
2026Q3E2026-08-03100-0.02-0.02-0.02
2026Q3E2026-05-20110-0.02-0.02-0.02
2026Q3E2026-03-27100-0.03-0.03-0.03
2026Q3E2026-02-03100-0.03-0.03-0.03

Estimate history

EPS, annual-1.11-1.05-0.643-0.457-0.339-0.474-0.593-0.542-0.262-0.2061
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.165-0.117-0.05-0.101-0.059-0.093-0.011-0.03-0.073
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual41.59342.643.44736.34753.90356.97251.86948.66952.67551.57
Period201720182019202020212022202320242025TTM
Sales, quarterly12.63111.58112.69611.89613.57112.48414.72411.79912.566
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual11.59613.60213.78513.915.87615.9916.25316.63617.30717.453
Period201720182019202020212022202320242025MRQ
Shares, quarterly16.44916.63616.63616.78916.81517.0517.30717.39517.453
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue51.5752.6748.6751.8756.9753.9036.3543.4542.60
Cost of Goods Sold Incl. D&A33.3733.7729.5030.3931.8331.2320.8025.5225.14
Gross Profit18.2118.9019.1721.4725.1422.6715.5417.9217.45
Selling, General and Administrative Excl. Other20.9921.4827.4731.4832.6830.2022.1226.9030.32
Research and Development3.763.405.186.567.016.763.283.684.01
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-2.78-2.57-8.30-10.01-7.54-7.53-6.58-8.97-12.87
Interest Expense---0.000.00--0.000.00
Unusual Expense0.000.000.000.000.00-2.500.000.050.15
Net Income Before Taxes-3.40-4.38-8.84-9.48-7.48-5.18-6.30-8.77-12.78
Income Taxes0.150.060.070.090.070.040.030.050.04
Consolidated Net Income-3.55-4.44-8.91-9.57-7.55-5.22-6.33-8.81-12.81
Net Income From Continuing Operations-3.55-4.44-8.91-9.57-7.55-5.22-6.33-8.81-12.81
Net Income-3.55-4.44-8.91-9.57-7.55-5.22-6.33-8.81-12.81
EPS (Recurring)-0.20-0.26-0.54-0.59-0.47-0.45-0.46-0.64-1.04
EPS (Basic, Before Extraordinaries)-0.21-0.26-0.54-0.59-0.47-0.34-0.46-0.64-1.05
EPS (Diluted)-0.21-0.26-0.54-0.59-0.47-0.34-0.46-0.64-1.05
EBITDA-1.26-1.02-6.88-7.97-6.16-6.73-6.08-8.29-12.06
Non-Operating Income (Expense)-0.62-1.81-0.540.530.06-0.150.280.260.24
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.580.610.981.301.281.190.821.241.42
Price To Sales Ratio0.380.380.560.870.561.750.960.741.27
Gross Margin35.3135.8939.3941.4044.1342.0542.7641.2540.97
Operating Margin-5.39-4.88-17.06-19.29-13.24-13.98-18.11-20.66-30.21
Net Margin-6.88-8.42-18.31-18.45-13.25-9.69-17.41-20.28-30.08
Shares Outstanding17.4517.3116.6416.2515.9915.8813.9013.7913.60
Market Capitalization12.3012.3027.9545.6632.1496.9434.8830.7363.89

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue12.5711.8014.7212.4813.5711.9012.7011.58
Cost of Goods Sold Incl. D&A8.357.149.338.558.976.847.147.39
Gross Profit4.224.665.403.934.605.055.554.19
Selling, General and Administrative Excl. Other5.254.995.415.345.545.266.056.06
Research and Development0.940.910.950.970.870.881.111.30
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.03-0.32-0.01-1.41-0.94-0.20-0.50-1.87
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-1.20-0.47-0.16-1.57-0.97-1.67-0.84-1.92
Income Taxes0.070.060.020.000.020.01-0.010.02
Consolidated Net Income-1.27-0.52-0.18-1.57-0.99-1.69-0.83-1.93
Net Income From Continuing Operations-1.27-0.52-0.18-1.57-0.99-1.69-0.83-1.93
Net Income-1.27-0.52-0.18-1.57-0.99-1.69-0.83-1.93
EPS (Recurring)-0.07-0.03-0.01-0.09-0.06-0.10-0.05-0.12
EPS (Basic, Before Extraordinaries)-0.07-0.03-0.01-0.09-0.06-0.10-0.05-0.12
EPS (Diluted)-0.07-0.03-0.01-0.09-0.06-0.10-0.05-0.12
EBITDA-0.670.050.41-1.04-0.560.18-0.12-1.59
Non-Operating Income (Expense)-0.17-0.14-0.15-0.16-0.03-1.47-0.34-0.05
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.170.170.170.070.200.170.250.09
Price To Sales Ratio0.380.320.380.390.300.340.570.61
Gross Margin33.5639.5036.6531.5033.9242.4943.7436.18
Operating Margin-8.19-2.75-0.10-11.30-6.93-1.72-3.95-16.15
Net Margin-10.07-4.44-1.25-12.60-7.32-14.17-6.57-16.69
Shares Outstanding17.4517.4017.3117.0516.8116.7916.6416.64
Market Capitalization12.3017.3619.6019.3814.8116.4727.9529.11

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments6.032.397.0313.9223.8511.6312.6521.1921.71
Short Term Receivables9.548.399.659.779.727.299.329.087.86
Inventories7.8810.829.9110.617.615.718.178.799.38
Other Current Assets1.801.960.861.471.070.730.400.550.50
Total Current Assets25.2523.5627.4535.7742.2525.3630.5539.6239.45
Net Property, Plant & Equipment0.831.912.982.132.991.883.491.221.40
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets1.952.272.612.943.170.600.620.630.65
Other Assets1.121.391.401.460.270.130.150.200.14
Total Assets29.1529.1434.4442.2948.6927.9734.8141.6741.65
Short Term Debt Incl. Current Port. of LT Debt0.702.830.991.040.932.661.410.000.00
Accounts Payable5.386.994.503.862.771.152.592.521.72
Income Tax Payable0.030.150.100.070.07--0.030.06
Other Current Liabilities7.096.607.387.498.874.885.778.558.61
Total Current Liabilities13.2116.5612.9712.4512.658.689.7811.0910.39
Long Term Debt3.831.811.750.731.731.531.790.000.00
Provision for Risks Charges0.000.000.140.110.060.080.160.240.20
Other Liabilities7.198.6610.0511.7710.960.310.380.390.53
Total Liabilities24.2327.0424.9125.0625.3910.6012.1111.7111.12
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value6.000.000.000.000.000.000.000.000.00
Common Equity-1.082.109.5217.2323.3017.3722.7029.9630.52
Total Shareholders Equity4.922.109.5217.2323.3017.3722.7029.9630.52
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity4.922.109.5217.2323.3017.3722.7029.9630.52
Total Liabilities & Stockholders Equity29.1529.1434.4442.2948.6927.9734.8141.6741.65
Book Value Per Share-0.060.130.591.081.471.251.652.202.63
Tangible Book Value Per Share-0.17-0.010.430.891.271.211.602.162.58
Full-Time Employees93931111301198994114116
Price to Book Ratio-5.1810.663.781.784.162.011.352.132.51
Return on Assets-15.22-28.03-24.95-16.59-13.63-20.16-23.05-30.76-28.66
Return on Equity-126.43-153.37-71.54-37.24-25.70-31.59-33.47-42.37-36.93
Return on Invested Capital-50.68-227.76-84.89-42.01-20.88-33.49-35.97-42.77-42.16
Quick Ratio1.320.771.352.022.742.262.292.782.89
Current Ratio1.911.422.122.873.342.923.123.573.80

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-3.55-4.44-8.91-9.57-7.55-5.22-6.33-8.81-12.81
Depreciation1.521.551.422.031.380.800.500.690.81
Other Funds (Non Cash)1.673.161.571.651.81-0.831.321.781.96
Funds from Operations-0.350.27-5.92-5.89-4.36-5.25-4.51-6.35-10.05
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-1.38-2.38-1.37-0.86-5.1613.471.27-1.560.02
Cash from Operating Activities-1.73-2.12-7.29-6.75-9.528.22-3.24-7.91-10.03
Capital Expenditures-0.27-0.14-0.01-0.11-0.29-0.21-0.10-0.13-0.44
Net Assets From Acquisitions0.000.000.000.000.00-5.340.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.00-0.38-0.39
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.27-0.14-0.01-0.11-0.29-5.56-0.09-0.51-0.83
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.006.000.000.080.0210.100.000.0010.57
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.006.000.000.080.0210.100.000.0010.57
Proceedsfrom Stock Options0.006.000.000.000.009.880.000.0010.47
Issuance or Reduction of Debt, Net0.000.042.660.000.000.002.500.000.00
Change in Long Term Debt0.000.042.660.000.000.002.500.000.00
Issuance of Long Term Debt0.004.002.880.000.000.002.500.000.00
Reduction of Long Term Debt0.00-3.96-0.220.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.10-0.07-0.06-0.09-0.09-0.63-0.03-0.16-0.19
Other Financing Activities Uses-0.10-0.07-0.06-0.09-0.09-0.63-0.03-0.16-0.19
Cash from Financing Activities-0.105.962.60-0.01-0.079.472.47-0.1610.38
Exchange Rate Effect0.00-0.070.05-0.03-0.050.10-0.160.04-0.04
Net Change in Cash-2.103.64-4.65-6.89-9.9312.23-1.03-8.54-0.51
Free Cash Flow-2.00-2.26-7.30-6.85-9.808.00-3.33-8.04-10.46
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Price to Free Cash Flow-----11.77---
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments4.684.596.035.576.787.24
Short Term Receivables7.098.429.549.5310.039.39
Inventories9.759.327.887.308.4410.14
Other Current Assets2.442.251.801.661.622.36
Total Current Assets23.9624.5825.2524.0726.8729.13
Net Property, Plant & Equipment0.400.640.831.061.331.62
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1.791.871.952.032.112.19
Other Assets1.111.191.121.201.271.30
Total Assets27.2628.2729.1528.3531.5934.24
Short Term Debt Incl. Current Port. of LT Debt0.140.420.701.031.151.12
Accounts Payable6.655.755.384.415.316.05
Income Tax Payable--0.03---
Other Current Liabilities6.386.657.096.967.257.78
Total Current Liabilities13.1712.8313.2112.3913.7114.95
Long Term Debt3.873.853.833.763.9210.18
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities6.576.867.197.527.898.26
Total Liabilities23.6223.5424.2323.6725.5333.38
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value6.006.006.006.006.000.00
Common Equity-2.36-1.27-1.08-1.320.060.85
Total Shareholders Equity3.644.734.924.686.060.85
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity3.644.734.924.686.060.85
Total Liabilities & Stockholders Equity27.2628.2729.1528.3531.5934.24
Book Value Per Share-0.14-0.07-0.06-0.080.000.05
Tangible Book Value Per Share-0.24-0.18-0.17-0.20-0.12-0.08
Full-Time Employees--93---
Price to Book Ratio-5.18-13.06-14.74324.9317.387.85
Return on Assets-12.06-10.48-15.22-17.39-17.34-20.88
Return on Equity-73.15-117.30-126.43-139.29-105.72-194.33
Return on Invested Capital-16.86-6.10-2.10-18.64-9.96-15.28
Quick Ratio1.081.191.321.351.341.27
Current Ratio1.821.921.911.941.961.95

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-1.27-0.52-0.18-1.57-0.99-1.69
Depreciation0.360.370.420.370.380.38
Other Funds (Non Cash)0.240.240.240.940.291.68
Funds from Operations-0.660.090.48-0.26-0.330.38
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.84-1.420.11-0.90-0.07-1.53
Cash from Operating Activities0.17-1.330.59-1.16-0.40-1.15
Capital Expenditures-0.05-0.10-0.11-0.01-0.01-0.01
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.05-0.10-0.11-0.01-0.01-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)---0.000.000.00
Change in Capital Stock0.000.000.000.000.006.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.006.00
Proceedsfrom Stock Options0.000.000.000.000.006.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.04
Change in Long Term Debt0.000.000.000.000.000.04
Issuance of Long Term Debt0.000.000.000.000.004.00
Reduction of Long Term Debt0.000.000.000.000.00-3.96
Net Financing Active Other Cash Flow-0.04-0.00-0.03-0.03-0.010.00
Other Financing Activities Uses-0.04-0.00-0.03-0.03-0.010.00
Cash from Financing Activities-0.04-0.00-0.03-0.03-0.016.04
Exchange Rate Effect-0.000.00-0.000.00-0.04-0.02
Net Change in Cash0.09-1.430.46-1.21-0.474.86
Free Cash Flow0.12-1.440.48-1.17-0.41-1.16

Revenue breakdown

Cyclo G Six2024: 12.70M 2025: 13.84M
Product and Service, Other2024: 8.15M 2025: 8.55M
Retina2024: 27.83M 2025: 30.28M
Americas Excluding U S2024: 2.21M 2025: 2.12M
Asia Pacific2024: 11.95M 2025: 12.95M
Europe, Middle East and Africa2024: 11.82M 2025: 14.39M
United States2024: 22.69M 2025: 23.21M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.37%0.0M10.7M388.39K
2026-10-150.71%0.1M10.7M394.16K
2026-09-301.21%0.1M10.9M67.60K
2026-09-151.48%0.2M10.9M69.48K
2026-08-311.36%0.1M10.9M71.73K
2026-08-140.35%0.0M10.8M56.92K
2026-07-310.27%0.0M10.7M56.40K
2026-07-150.30%0.0M11.9M57.16K
2026-06-300.25%0.0M12.2M252.92K
2026-06-150.18%0.0M12.2M255.74K
2026-05-290.23%0.0M12.2M250.56K
2026-05-150.23%0.0M12.4M247.09K
2026-04-300.48%0.1M11.7M253.59K
2026-04-150.90%0.1M11.6M271.99K
2026-03-310.28%0.0M11.7M84.69K
2026-03-130.41%0.0M11.7M87.21K
2026-02-270.39%0.0M11.7M92.59K
2026-02-130.63%0.1M11.7M97.32K
2026-01-301.18%0.1M11.7M107.55K
2026-01-152.31%0.3M11.7M88.10K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.250.046.0651.000.000.197-0.0100.000
call5.000.000.700.0013.6840.000.000.550-0.0310.000
call7.500.000.700.0014.7260.000.000.539-0.0330.000
put2.501.452.151.8313.0381.000.00-0.426-0.0260.000
put5.003.904.800.0019.7540.000.00-0.471-0.0310.000
put7.506.407.300.0020.8230.000.00-0.474-0.0340.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-134Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-074Statement of changes in beneficial ownership of securities2025-03-25SEC
2026-10-074Statement of changes in beneficial ownership of securities2025-03-25SEC
2026-10-074Statement of changes in beneficial ownership of securities2025-03-25SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-028-KCurrent report2026-08-27SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-1810-QQuarterly report pursuant to Section 13 or 15(d)2026-07-04SEC
2026-08-188-KCurrent report2026-08-18SEC
2026-07-168-KCurrent report2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-13SCHEDULE 13D/ASEC
2026-07-084Statement of changes in beneficial ownership of securities2026-07-07SEC
2026-06-188-KCurrent report2026-06-12SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-13SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-13SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-01SDSpecialized Disclosure ReportSEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-1910-QQuarterly report pursuant to Section 13 or 15(d)2026-04-04SEC
2026-05-198-KCurrent report2026-05-19SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-099.98K300
2026-085.00K100
2026-070000
2026-0611.41K500
2026-055.00K100
2026-040000
2026-0374.45K900
2026-02140.80K1100
2026-01154.47K1300
2025-12134.94K1400
2025-11124.40K1500

Institutional holders

Manager% owned
VANGUARD CAPITAL MANAGEMENT LLC2.96%
RENAISSANCE TECHNOLOGIES LLC2.43%
MORGAN STANLEY1.75%
WEBER CAPITAL MANAGEMENT LLC /ADV0.84%
GEODE CAPITAL MANAGEMENT, LLC0.79%
CITADEL ADVISORS LLC0.57%
VANGUARD FIDUCIARY TRUST CO0.35%
STATE STREET CORP0.26%
PERKINS CAPITAL MANAGEMENT INC0.23%
GOLDMAN SACHS GROUP INC0.23%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.31%
VANGUARD EXTENDED MARKET INDEX FUND0.65%
Fidelity Extended Market Index Fund0.41%
Fidelity Series Total Market Index Fund0.10%
Fidelity Total Market Index Fund0.08%
Fidelity Nasdaq Composite Index Fund0.06%

OakChart. IRIX. Cached 15 minutes.